DIASOLUTION is the spin-out company of Institute of Molecular Genetics and Genetic Engineering (IMGGE), University of Belgrade, founded in 2021. DIASOLUTION has a license agreement for clinical trial, development, registration and commercialization of the innovative probiotic for diabetes and prediabetes management.
Innovative diabetes management probiotic, a novel, completely natural product exhibiting protective effects on pancreas, liver and kidney cells that prevents the offset of diabetes complications, contributing in an efficient way to improvement of the quality of life of patients with diabetes and prediabetes without any side effect. The protective effects have been already proven in preclinical studies in rats and pilot veterinary clinical trials on pets. The first phase of clinical trial is ongoing.
Export markets: We are looking for local and global investors for scaling the company. Also looking for global distributor.
A: Cara Lazara 5-7, 11000 Belgrade, Serbia
M: +381 64 16 25 920